Average Co-Inventor Count = 5.41
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (70 from 3,681 patents)
2. Rhone-poulenc Rorer Pharmaceuticals Inc. (6 from 111 patents)
3. Aventis Pharma Deutschland, Gmbh (3 from 330 patents)
4. Bristol-myers Squibb (3 from 36 patents)
5. The Scripps Research Institute (2 from 1,186 patents)
6. Aventis Pharmaceuticals Inc. (2 from 207 patents)
7. University of Pennsylvania (1 from 2,595 patents)
85 patents:
1. 12428421 - Pyrimidinones as factor XIA inhibitors
2. 12077558 - Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compounds
3. 12065505 - Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof
4. 11613554 - Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds
5. 11192891 - Diazaspiro ROCK inhibitors
6. 11083704 - Method of administering nitroxyl donating compounds
7. 11053247 - Pyrimidinones as factor XIA inhibitors
8. 10752641 - Diamide macrocycles having factor XIa inhibiting activity
9. 10676477 - Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group
10. 10336754 - Pyrimidinones as factor XIa inhibitors
11. 10336730 - Substituted glycine derived FXIA inhibitors
12. 10287288 - Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties
13. 10273236 - Macrocyclic factor XIa inhibitors bearing heterocyclic groups
14. 10208068 - Macrocycles as factor XIa inhibitors
15. 10160750 - Diamide macrocycles as factor XIa inhibitors